Evidence map›Paper›PMID 33495532›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2021

Loss-of-function variants in SEMA3F and PLXNA3 encoding semaphorin-3F and its receptor plexin-A3 respectively cause idiopathic hypogonadotropic hypogonadism.

Leman Damla Kotan, Gaetan Ternier, Aydilek Dagdeviren Cakir, Hamdi Cihan Emeksiz, Ihsan Turan, Gaspard Delpouve, Asli Derya Kardelen, Bahar Ozcabi, Emregul Isik, Eda Mengen and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Genetics of Idiopathic Hypogonadotropic HypogonadismJournal of clinical research in pediatric endocrinology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 3 countries.

Leman Damla Kotan *Division of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.
Gaetan Ternier *Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France.
Aydilek Dagdeviren CakirDivision of Pediatric Endocrinology, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Hamdi Cihan EmeksizDivision of Pediatric Endocrinology, Istanbul Medeniyet University, Faculty of Medicine, Istanbul, Turkey.
Ihsan TuranDivision of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.
Gaspard DelpouveUniv. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France.
Asli Derya KardelenDivision of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Bahar OzcabiDivision of Pediatric Endocrinology, Health Sciences University, Zeynep Kamil Maternity and Children's Training and Research Hospital, Istanbul, Turkey.
Emregul IsikClinic of Pediatric Endocrinology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey.
Eda MengenClinic of Pediatric Endocrinology, Ankara City Hospital, Children's Hospital, Ankara, Turkey.
Esra Deniz P CakirDivision of Pediatric Endocrinology, Health Sciences University, Istanbul Bakırkoy Dr. Sadi Konuk Research and Training Hospital, Istanbul, Turkey.
Aysegul YukselClinic of Pediatric Endocrinology, Health Sciences University, Derince Training and Research Hospital, Kocaeli, Turkey.
Sebahat Yilmaz AgladiogluClinic of Pediatric Endocrinology, Memorial Hospital, Istanbul, Turkey.
Semine Ozdemir DilekDivision of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.
Olcay EvliyaogluDivision of Pediatric Endocrinology, Istanbul University, Cerrahpasa Faculty of Medicine, Istanbul, Turkey.
Feyza DarendelilerDivision of Pediatric Endocrinology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Fatih GurbuzDivision of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.
Gamze AkkusDivision of Endocrinology and Metabolism, Cukurova University, Faculty of Medicine, Adana, Turkey.
Bilgin YukselDivision of Pediatric Endocrinology, Cukurova University, Faculty of Medicine, Adana, Turkey.
Paolo Giacobini *Univ. Lille, Inserm, CHU Lille, U1172-LilNCog-Lille Neuroscience & Cognition, Lille, France. paolo.giacobini@inserm.fr.
A Kemal Topaloglu *Department of Pediatrics, Division of Pediatric Endocrinology, University of Mississippi Medical Center, Jackson, MS, USA. ktopaloglu@umc.edu.ORCID http://orcid.org/0000-0003-2931-9552
Cukurova University · TRInserm · FRIstanbul University · TRIstanbul University-Cerrahpaşa · TRBakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi · TRIstanbul Medeniyet University · TRIstanbul Memorial Hospital · TRJackson Memorial Hospital · USMemorial Ankara Hospital · TRSağlık Bilimleri Üniversitesi · TRZeynep Kamil Hospital · TR

Funding

European Research Council 725149
6 · The paper itself

Abstract

purposeIdiopathic hypogonadotropic hypogonadism (IHH) is characterized by absent puberty and subsequent infertility due to gonadotropin-releasing hormone (GnRH) deficiency. IHH can be accompanied by normal or compromised olfaction (Kallmann syndrome). Several semaphorins are known potent modulators of GnRH, olfactory, and vomeronasal system development. In this study, we investigated the role of Semaphorin-3F signaling in the etiology of IHH.

methodsWe screened 216 IHH patients by exome sequencing. We transiently transfected HEK293T cells with plasmids encoding wild type (WT) or corresponding variants to investigate the functional consequences. We performed fluorescent IHC to assess SEMA3F and PLXNA3 expression both in the nasal region and at the nasal/forebrain junction during the early human fetal development.

resultsWe identified ten rare missense variants in SEMA3F and PLXNA3 in 15 patients from 11 independent families. Most of these variants were predicted to be deleterious by functional assays. SEMA3F and PLXNA3 are both expressed along the olfactory nerve and intracranial projection of the vomeronasal nerve/terminal nerve. PLXNA1-A3 are expressed in the early migratory GnRH neurons.

conclusionSEMA3F signaling through PLXNA1-A3 is involved in the guidance of GnRH neurons and of olfactory and vomeronasal nerve fibers in humans. Overall, our findings suggest that Semaphorin-3F signaling insufficiency contributes to the pathogenesis of IHH.

Indexed as

HypogonadismSemaphorinsCell Adhesion MoleculesHEK293 CellsHumansMembrane ProteinsNerve Tissue ProteinsReceptors, Cell SurfaceCell Adhesion MoleculesMembrane ProteinsNerve Tissue ProteinsplexinPLXNA3 protein, humanReceptors, Cell SurfaceSEMA3F protein, humanSemaphorins

Identifiers

PMID33495532
PMCPMC7612467
OpenAlexW3124429268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.